Cermak Elizabeth 4
4 · POZEN INC /NC · Filed Oct 26, 2012
Insider Transaction Report
Form 4
POZEN INC /NCPOZN
Cermak Elizabeth
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2012-10-25+21,000→ 21,000 total
Footnotes (1)
- [F1]Restricted stock units granted pursuant to the POZEN Inc. 2010 Omnibus Equity Compensation Plan, which vests one-half (1/2) upon the acceptance by the FDA of the filing of an NDA for a low dose PA product, currently PA8140, and (b) one-half (1/2) upon approval by the FDA of an NDA for a low dose PA product, currently PA8140.